The categories of treatment options for breast cancer – surgery, chemotherapy, hormone therapy, and radiation therapy – remain the same since the 1980’s. Although there have been advancements and refinements in these treatments areas, Targeted Therapy being the most significant and many hormone suppressing drugs added over the years they still make women very sick, significantly reducing their quality of life and don’t do much to prevent recurrence. So in our book here a BCA these “advances” are not near good enough and should have progressed far beyond their current state by now.

Mastectomies are still butchering women’s bodies and breast reconstruction is still overall very poor quality. Women are told they are “lucky to be alive” and they should “be happy” with that and whatever breast reconstruction they get, regardless of how awful it looks. BCA finds those ridiculous statements by breast cancer medical professionals to be outrageous in 2025. Our Founder & BossLady, Roxann Abrams, experienced all of those statements in her very recent (2022) diagnosis and treatment over the last 3 years.

• Breast-conserving surgery, lumpectomy, is more common for early-stage breast cancer and mostly available to women with fatty breast tissue because mammograms miss breast cancer routinely in dense breast tissue causing diagnosis to be at a later stage requiring a mastectomy. However an FDA Approved surgery for non-canerous breast tumors – Cryoablation – that has been available for more than 20 years, is very effective for curing early stage breast cancer and preventing recurrences, is not conventional surgery, and requires very little down time with a very easy recovery – without the risks of surgery – and doesn’t require cosmetic surgery afterward to fix the breast deformity lumpectomy usually causes. But it is NOT FDA approved for breast cancer, although it IS approved for many types of cancer in internal organs such as kidney cancer, lung cancer, bowel cancer and bone. cancer – so it is clearly safe for the human body! So WHY is it not approved for early stage breast cancer? BCA asks: Could it be because it’s cheap compared to traditional surgery and effective so continued treatment (radiation & hormone suppressing drugs) are usually not needed — even though these treatments are routinely prescribed after lumpectomy. Ask yourself what is going on here?

   

• Mastectomy: yes there have been advances in this surgery, however not enough. This surgery  is still butchering to women’s bodies in 2025 because the way they are still performed, even in Skin and Nipple Sparing Mastectomies (NSM), The current techniques still leave much to be desired in the overall trauma to women’s bodies and the end reconstruction results. Unfortunately most women end up with a displaced Nipple Areola Complex (NAC), so although they have a nipple, it’s in the wrong place & requires another revision surgery to get a pleasing end result look because the anchoring techniques to keep it in place cannot be performed with expanders in place and most reconstruction surgeons perform a two stage reconstruction when one stage would suffice. Again BCA asks Why? BCA believes this is part of the medical industry “business” cash cow hampster wheel of cancer. It forces doctors who work for big medical centers (and most do) to use multiple surgeries instead of a direct-to-implant one surgery that encompasses mastectomy & implant surgery into one by teaching them. There are medical that 2 stages(or more) is needed, when it is not! There are medical facilities and private doctors in the US that do this one-stage direct-t0-implant surgery  regularly (even on women with larger breasts) with no additional patient recovery problems – but it is not the norm. BCA believes it should be.
  
  BCA also believes Robotic Mastectomies should be the norm in 2025,when a mastectomy is warranted and not an experimental surgery. We need innovative young surgeons who aren’t afraid of technology to step up and take the reins for women in breast cancer treatment.